Stockreport

Huonslab Announces Submission of Biologics License Application for Recombinant Human Hyaluronidase ‘HYDIZYME™' [Yahoo! Finance]

Halozyme Therapeutics, Inc.  (HALO) 
Last halozyme therapeutics, inc. earnings: 2/24 04:02 pm Check Earnings Report
US:NASDAQ Investor Relations: halozyme.com/investors/default.aspx
PDF PANGYO, South Korea, December 22, 2025 BUSINESS WIRE Huonslab , a subsidiary of Huons Global (KOSDAQ:084110), has submitted a Biologics License Application (BLA) to the [Read more]